HX GROUP(SH:600851)2018-04-27 16:00Financial Performance - The net profit attributable to shareholders for the reporting period was CNY 18.32 million, representing a year-on-year increase of 79.89%[6]. - Operating revenue for the period reached CNY 208.34 million, reflecting a growth of 12.56% compared to the same period last year[6]. - Basic earnings per share were CNY 0.0152, an increase of 80.95% year-on-year[6]. - The company reported a combined net profit increase of approximately CNY 3.6 million from its investments in pharmaceutical production enterprises[6]. - The rental income from shut-down industrial plants contributed an additional CNY 6 million to the combined net profit[6]. - Net profit for Q1 2018 reached CNY 15,317,238.31, significantly higher than CNY 3,708,007.82 in Q1 2017, marking an increase of 313.5%[25]. - The company reported an investment income of CNY 27,858,429.52, slightly up from CNY 27,263,122.21 in the previous year[25]. - The company reported an investment income of 28,737,145.57 RMB, an increase from 27,158,332.94 RMB in the previous period, showing a growth of about 5.83%[28]. Assets and Liabilities - The company's total assets at the end of the reporting period were approximately CNY 4.81 billion, a decrease of 1.78% compared to the end of the previous year[6]. - Cash and cash equivalents decreased by 38.82% to ¥305,501,441.15 from ¥499,314,247.60 due to investments in convertible bonds and partnerships[13]. - The total assets decreased to ¥4,805,040,746.56 from ¥4,892,139,818.15, reflecting a reduction in overall asset value[19]. - The total liabilities increased to ¥960,960,645.93 from ¥942,202,012.89, indicating a rise in the company's obligations[19]. - The total equity of the company was CNY 4,562,894,344.30, down from CNY 4,655,502,105.59, reflecting a decrease of 2.0%[23]. - The total current assets decreased to CNY 989,012,294.38 from CNY 1,066,824,725.37, a decline of 7.3%[22]. Cash Flow - The net cash flow from operating activities was negative at CNY -8.07 million, an improvement from CNY -46.51 million in the same period last year[6]. - Cash received from operating activities increased by 112.59% to ¥22,553,329.63 from ¥10,608,797.50, mainly due to loans from partners[13]. - Cash flow from operating activities shows a net outflow of -8,065,633.59 RMB, an improvement from -46,511,103.70 RMB in the previous period[31]. - Cash flow from investing activities results in a net outflow of -210,979,435.00 RMB, compared to -20,392,916.85 RMB in the previous period, indicating a significant increase in investment expenditures[32]. - The total cash outflow from investing activities amounted to $206,467,764.69, compared to $1,522,321.63 in the same period last year, indicating a substantial increase in investment expenditures[35]. - The total cash and cash equivalents decreased by $175,328,412.44 compared to a decrease of $7,821,598.77 in the previous year, indicating a significant decline in liquidity[35]. Shareholder Information - The total number of shareholders at the end of the reporting period was 72,774, with 37,107 holding A shares and 35,667 holding B shares[9]. - The top ten shareholders held a total of 6.66% to 6.80% of the company's shares, with the largest shareholder holding 82,082,000 shares[9]. Expenses - Sales expenses surged by 190.12% to ¥63,204,008.08 from ¥21,785,602.75, primarily due to increased advertising costs[13]. - The company’s management expenses increased to 10,133,617.86 RMB from 9,668,821.84 RMB, reflecting an increase of approximately 4.79%[28]. - The company paid $13,022,961.22 in employee compensation, an increase from $11,762,319.28 in the previous year, representing a growth of approximately 11%[35].